Kim Sang Jick, Hong Hyo Jeong
Therapeutic Antibody Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, Republic of Korea.
J Microbiol. 2007 Dec;45(6):572-7.
To enhance therapeutic potential of murine monoclonal antibody, humanization by CDR grafting is usually used to reduce immunogenic mouse residues. Most humanized antibodies still have mouse residues critical for antigen binding, but the mouse residues may evoke immune responses in humans. Previously, we constructed a new humanized version (AKA) of mouse CC49 antibody specific for tumor-associated glycoprotein, TAG-72. In this study, to select a completely human antibody light chain against TAG-72, guided selection strategy using phage display was used. The heavy chain variable region (VH) of AKA was used to guide the selection of a human TAG-72-specific light chain variable region (VL) from a human VL repertoire constructed from human PBL. Most of the selected VLs were identified to be originated from the members of the human germline VK1 family, whereas the VL of AKA is more homologous to the VK4 family. Competition binding assay of the selected Fabs with mouse CC49 suggested that the epitopes of the Fabs overlap with that of CC49. In addition, they showed better antigen-binding affinity compared to parental AKA. The selected human VLs may be used to guide the selection of human VHs to get completely human anti-TAG72 antibody.
为提高鼠单克隆抗体的治疗潜力,通常采用互补决定区(CDR)移植进行人源化,以减少具有免疫原性的小鼠残基。大多数人源化抗体仍保留对抗原结合至关重要的小鼠残基,但这些小鼠残基可能会在人体内引发免疫反应。此前,我们构建了一种针对肿瘤相关糖蛋白TAG-72的小鼠CC49抗体的新型人源化版本(AKA)。在本研究中,为筛选出针对TAG-72的完全人源化抗体轻链,采用了基于噬菌体展示的导向筛选策略。利用AKA的重链可变区(VH)从由人外周血淋巴细胞构建的人VL文库中导向筛选人TAG-72特异性轻链可变区(VL)。大多数筛选出的VL被鉴定为源自人胚系VK1家族成员,而AKA的VL与VK4家族的同源性更高。所选Fab片段与小鼠CC49的竞争结合试验表明,这些Fab片段的表位与CC49的表位重叠。此外,与亲本AKA相比,它们表现出更好的抗原结合亲和力。所选的人源化VL可用于导向人源化VH的筛选,以获得完全人源化的抗TAG72抗体。